Biochemistry, Genetics and Molecular Biology
Infectious Agent
100%
Serotype
100%
Polysaccharide
50%
Comorbidity
50%
Cohort Study
50%
Mortality Rate
50%
Antibiotic Sensitivity
50%
Ceftriaxone
50%
Penicillin
50%
Levofloxacin
50%
Immunology and Microbiology
Infectious Agent
100%
Serotype
100%
Vaccine Efficacy
50%
Pneumococcal Vaccine
50%
Penicillin
50%
Comorbidity
50%
Mortality Rate
50%
Antibiotic Sensitivity
50%
Pneumococcal Polysaccharide Vaccine
50%
Keyphrases
Israel
100%
Invasive Pneumococcal Disease
100%
Sick
100%
Hospital-onset
100%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
10%
Hospitalization
5%
PCV7
5%
Pneumococcal Conjugate Vaccine
5%
Vaccine Serotypes
5%
Resistant Strains
5%
Penicillin
5%
Comorbidity
5%
Retrospective Cohort Study
5%
Mortality Rate
5%
Patient Characteristics
5%
High Mortality
5%
High Morbidity
5%
Long-term Care Facilities
5%
Disease Case
5%
Antimicrobial Susceptibility
5%
Adult Age
5%
Ceftriaxone
5%
Pneumococcal Polysaccharide Vaccine
5%
Levofloxacin
5%
Vaccine Program
5%
PPSV23
5%
Medicine and Dentistry
Pathogen
100%
Pneumococcal Infection
100%
Serotype
10%
Mortality Rate
5%
Pneumococcus Vaccine
5%
Antibiotics
5%
Penicillin Derivative
5%
Retrospective Cohort Study
5%
Patient Characteristics
5%
Antibiogram
5%
Polysaccharide Vaccine
5%
Pneumococcus Polysaccharide
5%
Ceftriaxone
5%
Levofloxacin
5%
Long-Term Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infectious Agent
100%
Pneumococcal Infection
100%
Mortality Rate
5%
Antiinfective Agent
5%
Antibiotics
5%
Pneumococcus Vaccine
5%
Penicillin Derivative
5%
Comorbidity
5%
Cohort Study
5%
Ceftriaxone
5%
Polysaccharide Vaccine
5%
Levofloxacin
5%
Pneumococcus Polysaccharide
5%